Oncologists & Specialists
A trusted network of professionals
OncoloMed has built up a large network of trusted and well-recognised doctors from across the world, who are leaders and pioneers in their domains. A small selection of oncologists from our network are shown below:
Professor of Cancer Medicine and Oncology, Consultant Oncologist, Imperial College and Imperial College Healthcare NHS Trust.
Professor Justin Stebbing
Prof. Justin Stebbing specialises in a range of malignancies and their treatment with immunotherapy. His original PhD research investigated the interplay between the immune system and cancer. Appointed a senior lecturer in 2007, and a Prof. in 2009. he has published over 600 peer-reviewed papers (Lancet, New England Journal, Blood, the Journal of Clinical Oncology etc). His focus at Imperial is on new therapies in cancer, and the systemic management of patients with solid malignancies.
Pioneer Regional Chemotherapy
Prof. Dr. Karl R. Aigner
Prof. Dr. Karl Aigner is one of the pioneers of regional chemotherapy worldwide. He has been working with RCT for more than 40 years and is one of the most experienced doctors of this treatment method. Numerous lectures and guest operations in the USA, Japan, China, Israel, Egypt, Russia, Australia and many other countries as well as over 250 Specialist publications, lectures and guest operations in Germany and abroad document his medical commitment to RCT – regional chemotherapy.
Professor of radiology at Imperial College London
Prof. Edward Leen
Professor Edward Leen is a professor of radiology at Imperial College London and an interventional radiologist treating cancer patients at Hammersmith, Charing Cross, St. Mary’s and The Princess Grace Hospital in London. He has over 15 years of experience with ablation treatments and techniques, and has treated over 1,500 patients with liver, lung, pancreas and kidney tumors.
Prof. Roberto Orecchia
Roberto Orecchia has been with the IEO since 1995, as Director of Radiotherapy, and has given his life to the Center for Advanced Radiotherapy, which is today a globally leading center for technological equipment and the number of patients treated in Italy. He is considered an authority at international level for research on cutting-edge radiotherapy methods and on the integration of radiation therapy with other forms of tumor treatment.
Oncologist at Erasmus MC Cancer Institute
Martjin Lolkema is a board certified medical oncologist at the Erasmus MC Cancer Institute in Rotterdam. He was intimately involved in designing and building a national collaborative group to implement Next Generation Sequencing for cancer patients: the Center for Personalized Cancer Treatment (CPCT). In 2014 Dr. Lolkema joined the Erasmus MC Cancer Institute to work on drug development in early phase clinical trials and translational research focused on prostate cancer.